Allied healthcare products inc (AHPI)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10
Cash flows from operating activities:
Net loss

-2,950

-2,241

-1,489

-2,109

-1,778

-3,058

-2,659

-2,192

-2,543

-2,045

-2,039

-2,088

-1,876

-2,257

-2,591

-2,304

-2,543

-2,262

-1,598

-1,777

-1,603

-2,069

-2,923

-2,805

-2,556

-1,866

-1,436

-1,256

-1,315

-1,181

-690

-424

-153

52

147

204

0

0

0

Adjustments to reconcile net loss to net cash provided (used in) by operating activities:
Depreciation and amortization

648

709

783

822

863

891

909

931

951

1,003

1,047

1,090

1,131

1,159

1,193

1,228

1,261

1,275

1,294

1,311

1,322

1,331

1,310

1,280

1,261

1,271

1,303

1,306

1,326

1,306

1,283

1,283

1,238

1,236

1,292

1,361

0

0

0

Stock based compensation

2

2

3

3

3

2

2

2

2

2

2

2

2

2

2

2

3

3

4

4

5

5

6

9

19

28

37

44

44

44

45

44

37

30

23

20

0

0

0

Provision for doubtful accounts and sales returns and allowances

21

10

21

19

13

-5

-12

-12

-5

0

0

10

10

10

13

2

9

36

49

61

66

40

33

18

1

-0

7

10

28

27

26

27

0

0

0

-

-

-

-

Provision for doubtful accounts and sales returns and allowances

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Deferred tax provision

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

290

-123

-123

-123

0

-74

-74

-74

-352

-278

-1,026

-1,031

-757

-792

-257

-257

-257

-174

37

39

41

0

0

0

Changes in operating assets and liabilities:
Accounts receivable

241

-475

-2

-563

-293

-162

-243

373

285

307

222

-721

-692

-444

-318

522

400

488

25

-76

-53

-185

-24

-490

310

-186

-200

-741

-610

-583

-1,366

-446

-1,170

-15

-482

-50

0

0

0

Inventories

-1,072

-640

-1,198

-497

-509

-968

-582

-681

-216

255

74

-363

-422

-247

-163

-315

-340

-521

-344

-215

-909

-844

-677

67

567

414

-95

-662

-612

-1,023

-410

-552

-877

-351

-202

-602

0

0

0

Income tax receivable

-1

-1

-7

0

-1

0

6

-0

0

0

-4

0

-2

-3

-4

0

-5

-5

-5

-4

-9

-11

-20

-19

39

-544

-253

-9

0

414

114

-49

-776

-641

-677

-782

0

0

0

Other current assets

21

20

73

-5

33

-20

-121

-65

10

27

-76

59

-71

-136

-12

-73

-83

-197

-58

-81

-61

-46

-127

-10

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Other assets, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-76

174

290

275

408

266

239

-8

0

0

0

Accounts payable

-142

10

-460

-4

193

-196

461

33

160

715

-231

-424

-983

-608

221

495

1,063

765

41

300

-468

-484

-157

-248

554

-2

-139

-479

-275

-334

38

152

-393

-95

-389

-305

0

0

0

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-114

-286

-458

-630

-688

-688

-688

-688

-688

0

0

0

Other accrued liabilities

962

810

-157

243

-19

163

-427

-159

128

-87

299

-331

-797

-331

-303

181

305

322

341

535

216

-310

-97

-237

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Other accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

84

-205

-46

-615

0

0

0

Net cash provided by (used in) operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

253

390

814

498

-473

-1,052

-1,882

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) operating activities

1,477

417

-144

59

141

-1,024

-621

-859

-1,219

-836

-1,107

-686

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

2,377

1,123

1,505

1,477

0

0

0

Cash flows from investing activities:
Capital expenditures

47

28

26

0

0

0

0

-

-

-

-

21

21

11

82

99

99

154

117

141

200

272

300

438

849

973

1,285

1,367

1,521

1,944

1,981

2,210

1,808

1,160

799

348

0

0

0

Net cash used in investing activities

-47

-28

-26

0

0

0

0

-

-

-

-

-21

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-1,804

-1,156

-795

-344

0

0

0

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-99

-154

-117

-141

-200

-272

-300

-438

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows from financing activities:
Borrowings under revolving credit agreement

32,024

31,599

32,662

32,176

32,124

31,941

22,914

14,774

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments under revolving credit agreement

32,435

31,970

32,190

32,176

32,396

30,585

22,536

14,774

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-410

-370

472

0

-272

1,356

377

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

45

116

116

0

0

0

Net increase (decrease) in cash and cash equivalents

1,019

18

301

59

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

0

0

-1,120

-

-930

-791

-633

-336

-93

99

273

673

298

-745

-1,352

-2,321

-2,798

-2,302

-2,308

-1,596

-2,047

-1,665

-778

-1,228

572

11

825

1,249

0

0

0